<span>Roadmap: Labcorp's approach to next generation risk assessment</span>
November 12, 2023

Roadmap: Labcorp's approach to next generation risk assessment

SETAC NA 2023 -- Current approaches for the safety assessment of human health and environmental risks due to chemical exposure have heavily relied on using animal models. The approach has generally been conservative and as such there has been a reluctance to change the way we perform risk assessments.
Read more »
<span>Nonproprietary assays TA Update multi-analyte methods</span>
November 29, 2023

Nonproprietary assays TA Update multi-analyte methods

From preclinical research through clinical development, we're here to help you at every stage of the continuum to deliver accurate, on-time results and advance your program. To meet your program's requirements, our GLP, nonproprietary methods have been developed according to FDA Crystal City and current regulatory guidelines.
Read more »
<span>Supporting a rapidly growing biotech with a unique ocular gene therapy</span>
November 30, 2023

Supporting a rapidly growing biotech with a unique ocular gene therapy

An emerging biotech company needed a flexible partner to support preclinical and clinical development of their viral vector-based gene therapy. We helped the biotech Sponsor by performing studies necessary to transition from the preclinical phase to first in human trials and beyond, while adapting to changing needs of a rapidly evolving program.
Read more »